|
Synonyms: IMO-2125 | IMO2125
Compound class:
Nucleic acid
Comment: Tilsotolimod (IMO-2125) is a phosphorothioate (P-thio) CpG oligonucleotide that is intended to act as a Toll-like receptor 9 (TLR9) agonist. Structurally it is a symmetrical, dual-strand 3'-3'-linked molecule.
Full sequence is : O,O'-(2-hydroxypropane-1,3-diyl) bis(hydrogen all-P-ambo-P-thiothymidylyl-(3'→5')-2'-deoxy-P-thiocytidylyl-(3'→5')-2'-deoxy-7-carba-P-thioguanylyl-(3'→5')-2'-deoxy-P-thioadenylyl-(3'→5')-2'-deoxy-P-thioadenylyl-(3'→5')-2'-deoxy-P-thiocytidylyl-(3'→5')-2'-deoxy-7-carba-P-thioguanylyl-(3'→5')-P-thiothymidylyl-(3'→5')-P-thiothymidylyl-(3'→5')-2'-deoxy-P-thiocytidylyl-(3'→5')-2'-deoxy-7-carba-P-thio-3'-guanylate) |
Classification ![]() |
|
| Compound class | Nucleic acid |
| Compound subclass | CpG oligonucleotide |
| Target | TLR9 |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 10634 | tilsotolimod |
Synonyms ![]() |
| IMO-2125 | IMO2125 |
Database Links ![]() |
|
| CAS Registry No. | 1948266-37-2 (source: WHO INN record) |
| DrugBank Ligand | DB16341 |
| Search PubMed clinical trials | tilsotolimod |
| Search PubMed titles | tilsotolimod |
| Search PubMed titles/abstracts | tilsotolimod |